Viking Therapeutics, Inc. (VKTX)
28.58
-0.17
(-0.59%)
USD |
NASDAQ |
Feb 11, 16:00
31.35
+2.77
(+9.69%)
After-Hours: 16:23
Viking Therapeutics Market Cap : 3.231B for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 908.35B |
| Pfizer Inc. | 157.55B |
| Amgen, Inc. | 197.49B |
| Biogen, Inc. | 28.06B |
| Regeneron Pharmaceuticals, Inc. | 82.40B |
Market Cap Related Metrics
| PEG Ratio | -0.1070 |
| Price to Book Value | 4.531 |
| Price | 28.58 |
| Earnings Yield | -7.41% |
| PEGY Ratio | -0.1070 |